response to ‘what kind of controls to use in case control studies of malformed infants: recall...

1
Response to ‘What Kind of Controls to Use in Case Control Studies of Malformed Infants: Recall Bias Versus “Teratogen Nonspecificity” Bias’ To the Editor: We read with interest the letter by Hook (’00) and greatly appreciated his positive view of our work (Pri- eto and Martı ´nez-Frias, ’99). Hook proposed the use of both healthy and malformed controls assuming that the true estimate of the relative risk is somewhere between the values obtained from these two proce- dures. We fully agree with his suggestion, but would like to add that an odds ratio (OR) with a magnitude over the unity of using malformed infants as controls, could also result from the quotient of two protective relative risks. For this reason, the value obtained using malformed infants as controls when the factors being studied have a protective effect is not the lower limit of the true estimate of the relative risk. Thus, in studies for generating hypotheses for factors with unknown effects, it is essential to use both healthy and mal- formed controls, not only as a way to control “recall bias” and “teratogen nonspecificity bias” as proposed by Hook, but also to identify whether the factor is terato- genic or protective. LUIS PRIETO Departamento de Bioestadı ´stica Facultad de Medicina Universidad Complutense Madrid, Spain MARI ´ A LUISA MARTI ´ NEZ-FRIAS* Departamento de Farmacologı ´a Facultad de Medicina Universidad Complutense Madrid, Spain LITERATURE CITED Hook EB. 2000. What kind of controls to use in case control studies of malformed infants: recall bias versus “Teratogen nonspecificity” bias. Teratology 61:325–326. Prieto L, Martı ´nez-Frias ML. 1999. Case-control studies using only malformed infants: are we interpreting the results correctly? Tera- tology 60:1–2. *Correspondence to: Marı ´a Luisa Martı ´nez-Frias, ECEMC and De- partamento de Farmacologı ´a, Facultad de Medicina, Universidad Complutense, Madrid 28040, Spain. E-mail: [email protected] Received 1 July 2000; Accepted 9 July 2000 TERATOLOGY 62:372 (2000) © 2000 WILEY-LISS, INC.

Upload: luis-prieto

Post on 06-Jun-2016

213 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Response to ‘what kind of controls to use in case control studies of malformed infants: Recall bias versus “Teratogen nonspecificity” bias’

Response to ‘What Kind of Controls to Use in CaseControl Studies of Malformed Infants: Recall BiasVersus “Teratogen Nonspecificity” Bias’

To the Editor:We read with interest the letter by Hook (’00) and

greatly appreciated his positive view of our work (Pri-eto and Martınez-Frias, ’99). Hook proposed the use ofboth healthy and malformed controls assuming thatthe true estimate of the relative risk is somewherebetween the values obtained from these two proce-dures. We fully agree with his suggestion, but wouldlike to add that an odds ratio (OR) with a magnitudeover the unity of using malformed infants as controls,could also result from the quotient of two protectiverelative risks. For this reason, the value obtained usingmalformed infants as controls when the factors beingstudied have a protective effect is not the lower limit ofthe true estimate of the relative risk. Thus, in studiesfor generating hypotheses for factors with unknowneffects, it is essential to use both healthy and mal-formed controls, not only as a way to control “recallbias” and “teratogen nonspecificity bias” as proposed byHook, but also to identify whether the factor is terato-genic or protective.

LUIS PRIETODepartamento de BioestadısticaFacultad de MedicinaUniversidad ComplutenseMadrid, Spain

MARIA LUISA MARTINEZ-FRIAS*Departamento de FarmacologıaFacultad de MedicinaUniversidad ComplutenseMadrid, Spain

LITERATURE CITED

Hook EB. 2000. What kind of controls to use in case control studies ofmalformed infants: recall bias versus “Teratogen nonspecificity”bias. Teratology 61:325–326.

Prieto L, Martınez-Frias ML. 1999. Case-control studies using onlymalformed infants: are we interpreting the results correctly? Tera-tology 60:1–2.

*Correspondence to: Marıa Luisa Martınez-Frias, ECEMC and De-partamento de Farmacologıa, Facultad de Medicina, UniversidadComplutense, Madrid 28040, Spain.E-mail: [email protected]

Received 1 July 2000; Accepted 9 July 2000

TERATOLOGY 62:372 (2000)

© 2000 WILEY-LISS, INC.